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Abstract 
BACKGROUND: The lives of individuals diagnosed with HIV and the subsequent illness, AIDS, were often 
chaotic because these individuals deal with the physical, emotional, and interpersonal sequelae of this illness. 
Depressive symptoms and stress were common and impact on functioning, quality of life, and health status, 
highlighting the importance of diagnosis and treatment of patients with HIV infection. Psychiatric clinical practice 
and rating scales have come to play an ever-increasing role both in determining specific symptoms and 
diagnosing an individual condition. Descriptive reports of psychiatric morbidity among those with HIV infection, 
that relied primarily on self-report rating scales, described high rates of symptomatic depression and stress.  
AIM: This study aimed to determine the proportion of depression among people living with HIV/AIDS using the 
BDI-II and PSS to determine a relationship between symptoms of depression and stress with CD4 counts. 
METHODS: This study was a numerical correlative analytic study with a cross-sectional study approach that 
assessed the correlation between stress, depression and CD4 level in people with HIV/AIDS that were receiving 
ARV therapy in the Voluntary Counselling Test (VCT) Polyclinic of General Hospital Haji Medan by recruiting 46 
subjects. CD4 level was examined in the Pramita Medan laboratory. 
RESULTS: When analysis of BDI-II level and CD4 scores were done, a significant correlation was found (P < 
0.05). The strength of the relationship between the BDI score and the CD4 score was 0.548 revealing a positive 
correlation with moderate correlation strength 
CONCLUSION: We have shown a significant relationship between depression, stress and CD4 level among 
people with HIV/AIDS in Medan, Indonesia. Psychological distress may affect the immunity in infected people, 
leading to the disease progressivity. 
 
 
 
 
 
Introduction 
 
HIV/AIDS was first launched in 1981 in 
California [1]. According to the United Nations 
Program on HIV/AIDS (UNAIDS) data, it is estimated 
that in 2016 the total number of people living with HIV 
was around 36.7 million people with new HIV infection 
rates reaching 1.8 million. The report on the highest 
number of HIV prevalence in the world comes from 
Africa, with an estimated 5.1 million people. UNAIDS 
data in 2016 also showed the prevalence of people 
living with this infection in Indonesia reaching 620,000 
with a new infection rate of 48,000 [2]. 
Based on data in 2014, HIV infections people 
were most prevalent in the heterosexual group 
(61.5%), followed by Injection Drug Users (IDU, 
15.2%) and homosexuals (2.4%), and unknown risk 
factors (17.1%) [3]. 
While report on the situation of the 
development of HIV/AIDS and Sexually Transmitted 
Infectious Diseases (STID) in Indonesia between 
January-March 2017, the highest number of HIV 
infections according to the risk factors was in men like 
men (MLM) (28%, n = 2,867), followed by 
heterosexual risk factors (24%, n = 2,448) [4]. 
HIV is a cytopathic virus classified in the 
Retroviridae family, subfamily Lentiviridae, Lentivirus 
genus. Based on its structure HIV belongs to the 
family of retroviruses, including the RNA virus with a 
molecular weight of 9.7 kb (kilobases) [5]. Human 
Immunodeficiency Virus (HIV) is a retrovirus that 
infects cells and the immune system [6].  
Acquired Immune Deficiency Syndrome 
(AIDS) is a collection of symptoms or diseases 
caused by decreased immunity due to infection with 
HIV which belongs to the retroviridae family. AIDS is 
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the final stage of HIV infection. People with HIV and 
AIDS abbreviated as ODHA in Bahasa (Indonesian 
Language) are people who have been infected with 
HIV [7]. The course of HIV infection, CD4 T-
lymphocyte count, number of viruses and clinical 
symptoms are classified into 3 phases: acute infection 
phase, latent phase of infection, chronic infection 
phase [5]. 
Psychosocial factors can influence the 
disease process with various biological parameters 
that reflect the progression of HIV infection, triggering 
a biological response through the limbic axis of the 
hypothalamic-pituitary-adrenal and sympathetic 
nervous system. Psychosocial factors with a high BDI-
II score, high neurohormone factors such as cortisol 
and norepinephrine (NE) will significantly affect the 
progression of HIV infection to AIDS, resulting in CD 
level and an increase in the number of viruses [8], [9]. 
The Beck Depression Inventory is a self-
assessment questionnaire for depression. BDI-II was 
developed as a concomitant level of validity and 
discriminant is acceptable among patients with HIV 
with an acceptable level of internal consistency. 
Analysis of the Main Components of BDI-II found 
three components with moderate correlation, one that 
assessed cognitive dimensions, the second assessed 
affective dimensions and the third with automatic 
dimensions of depression. While HIV and depression 
both have an automatic component, depression has 
affective, cognitive and automatic manifestations, with 
affective symptoms emerging as a disease while 
cognitive symptoms appear later, right for the 
assessment of the initial presentation of depression. 
Because of the symptoms of HIV infection and 
depression, it may be a symptom that is caused solely 
by depression [10]. 
In HIV infection, fatigue is formulated with the 
emergence of pathological, diffuse and extensive cell 
apoptosis which mainly attacks T lymphocytes so that 
the total and CD4 lymphocyte counts will gradually 
decrease. Psychological stress also triggers an 
increase in cortisol and catecholamine, which results 
in a decrease in the secretion of IL-1 and IL-2 by 
macrophages and a decrease in antibody 
formation/decrease in body resistance. The low IL-1 
results in a decrease in T-helper monocytes and 
lymphocytes resulting in a decrease in antibody 
formation, and a decrease in phagocytic activity of 
inflammatory cells against germs that cause infection, 
thus individuals become susceptible to infection. 
While the increase in catecholamine results in 
suppression of T-helper cell activity and function. So, 
with the decrease in immunoglobulins, lymphocyte 
activity, and NK cells can be used as an indicator of 
psychological stress followed by suppressing the 
activity of the ability of macrophages and killer cells in 
the lysis of the virus [11]. 
Life stress can dramatically disturb people 
and their ability to function. Many studies have shown 
that the onset of episodes of depression is 
etiologically related to stressful life events. Stress can 
occur which causes induction of depressive symptoms 
in HIV-positive people. Roberts et al. conducted a 
cross-sectional study exploring the impact of stressful 
life events on emotional stress and life-threatening 
HIV-positive people. The relationship between acute 
life events and perceived stress affects the 
psychological state of dysfunctional attitudes, self-
esteem, and neuroticism [12]. 
Based on the background mentioned above, 
the present study aimed to evaluate the relationship 
between CD4, stress, and depression in HIV/AIDS.  
 
 
Material and Methods 
 
Participants and Procedure 
This study was a numerical correlative 
analytic study with a cross-sectional study approach 
that assessed the correlation between stress, 
depression and CD4 level in people with HIV/AIDS 
that were receiving ARV therapy in the Voluntary 
Counselling Test (VCT) Polyclinic of General Hospital 
Haji Medan by recruiting 46 subjects. CD4 level was 
examined in the Pramita Medan laboratory. The study 
period was from January to February 2019. Patients 
were recruited consecutively. Inclusion criteria 
included people with HIV/AIDS based on the WHO 
criteria, aged 20-50 years, had been diagnosed less 
than four years, received ARV therapy > 6 months, 
agreed to participate and could be interviewed, with 
last education at least Elementary School or 
equivalent. Exclusion criteria were people who had a 
history of mental disorders.  
 
Beck's Depression Inventory-II 
BDI-II is a 21-item scale measuring 
depression manifestations carried out by participants, 
with high internal consistency. It took about 10 
minutes to complete. Each item consists of four 
statements (rated 0-3). Describes increasing the 
severity of the disorder in question. The interpretation 
of the results is as follows: a score of 5-9 shows 
normal ups and downs, 10-18 mild to moderate 
depression; 19-29 moderate to severe depression and 
30-63 major depression [13]. 
 
Perceived Stress Scale 
The Perceived Stress Scale (PSS) is used to 
measure psychological pressure. This instrument is a 
questionnaire consisting of 14 items that assess 
thoughts and feelings related to distress. Participants 
are asked on a 5-point scale to show how often they 
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have the same thoughts or feelings (0 never, 4 very 
often) [12]. 
 
CD4 T-lymphocytes 
CD4 T lymphocytes are the main target for 
HIV infection due to viral affinity for CD4 surface 
markers. CD4 T-lymphocytes coordinate important 
immunological functions; loss of these functions 
shows a progressive decrease in the immune 
response. The results of CD4+ T-lymphocyte 
examination are used as the basis for clinical 
management and therapy of HIV-infected people. 
There are three categories of CD4 T-lymphocytes as 
follows: category 1 (500 cells/μl), category 2 (200-499 
cells/μL), and category 3 (< 200 cells/μl) [13]. 
Infecting HIV T helper lymphocytes or via 
CD4 antigens. These infected lymphocytes then lysis 
when the new virion is released or removed by the 
cellular system immune. In progressive HIV infection, 
the T-lymphocyte CD4 is in number downhill. The 
absolute number of CD4 is an important measurement 
for predict, determine degrees, and monitor 
progression as well as response to treatment in HIV 
infection. Check the number of viruses' complete 
laboratory inspection for disease monitoring. The size 
inversely proportional to CD4, so the number of CD4 
and the number of viruses immediately shows the 
patient's immune status. This is useful for determining 
a diagnosis, prognosis, and management of 
medication in patients who are infected with HIV [14]. 
 
Data Analysis 
Subjects who fulfilled the criteria were asked 
for consent to take part in the study. They completed 
the demographic data and filled in the BDI-II and PSS 
questionnaires. Blood samples were taken to 
determine the CD4 level of the subjects.   
Measurement of CD4 level was carried out in 
a private laboratory in Medan using flow cytometric. 
Flow cytometry is a method that can be used 
for identifying the surface characteristics of each cell 
with ability separating cells that are in a suspension 
according to the characteristics each automatically 
through a gap penetrated by a beam of laser light. 
The method of flow cytometry continues to grow in 
line with electrical development of computers and 
reagents, including their use of a monoclonal 
antibody. Until now, measurements with flow 
cytometry use fluorescence labels, in addition to 
measuring cell size, too can detect cell wall markers, 
intracellular granules, infra-structure cytoplasm, and 
the cell nucleus. 
All data were processed with SPSS. Before 
data analysis, normality test using the Shapiro-Wilk 
test was carried out because numbers of samples 
were less than 50. Then data were analysed to obtain 
a correlation value (r). If data were normally 
distributed, data was going to be analysed using the 
Pearson Correlation test. If data was not normally 
distributed, data analysis was performed using the 
Spearman correlation test. A value of p < 0.05 was 
considered significant. 
 
Ethical Consideration 
This study was approved by the Ethical 
Committee of Research, Faculty of Medicine 
Universitas Sumatera Utara (ID 215/KEPK FK USU-
RSUP HAM/2018). Informed verbal consent was 
ensured before administration of the questionnaire. 
The beneficiaries were taken into consideration, and 
subjects were not coerced to participate in the study 
and confidentiality was maintained. 
 
 
Results  
 
We enrolled 46 patients in the study. The 
demographic description of patients was presented in 
Table 1. Variables with categorical scales were 
presented in frequency and proportion, and variables 
with numerical scales are presented in mean and 
standard deviation. 
Table 1: Distribution of Demographic Characteristics of 
Participants 
Variable n % 
Gender   
Male 28 60.9 
Female 18 39.1 
Age (year)   
20-30 21 45.7 
31-40 20 43.5 
41-50 5 10.9 
Education   
Junior High School 7 15.2 
Senior High School 21 45.7 
Undergraduate 18 39.1 
Marital Status   
Single 27 58.7 
Married 19 41.3 
HIV stage   
I 19 41.3 
II 22 47.8 
III/IV 5 10.9 
Transmission   
Sex 21 45.7 
Drugs 25 54.3 
 
Table 1 showed that the proportion of the sex 
of patients was male (60.9%) and female (39.1%). 
The age distribution was 20-30 years (45.7%), 31-40 
years (43.5%), and 41-50 years (10.9%). 
The proportion of patients with junior high 
school education, high school education, and 
undergraduate education were 15.2%, 45.7%, and 
39.1%, respectively. The majority of patients also 
went into HIV stage I (41.3%) and stage II (47.8%), 
while the remaining were classified as stage III-IV 
(10.9%). HIV transmission occurred through sex 
(45.7%) and drugs (54.3%). 
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Table 2: Distribution of stress (PSS scores) and depression 
(BDI-II Scores) among HIV Patients 
Variable Average SD Min Max 
BDI-II 46.35 16.60 24 63 
PSS 30.63 8.12 15 40 
 
Table 2 showed that the PSS scores with a 
mean of 30.63, the standard deviation of 8.12, a 
minimum value of 15, and a maximum value of 40. 
The BDI-II score with a mean of 46.35 and a standard 
deviation of 16.60, a minimum value of 24, and a 
maximum value of 63.  
Table 3: Distribution of CD4 among HIV Patients 
Variable Average SD Min Max 
CD4 345,30 104.67 158 564 
 
Table 3 showed that CD4 counts with a mean 
of 345.00, the standard deviation of 104.46, the 
minimum value of 158, and the maximum value of 
564. 
The Shapiro Wilk Test showed that the CD4 
score was normally distributed. Therefore a correlative 
test of baseline data used the Pearson Correlation 
test. When analysis of BDI-II level and CD4 scores 
were done, a significant correlation was found (P < 
0.05). The strength of the relationship between the 
BDI score and the CD4 score was 0.548 revealing a 
positive correlation with moderate correlation strength 
(r = 0.5 - < 0.6). 
The results of the Pearson Correlation test for 
PSS level and CD4 scores obtained a P-value of < 
0.05, showing a significant correlation between PSS 
and CD4 score. The strength of the relationship 
between PSS scores and CD4 was 0.45 meaning a 
positive correlation with moderate correlation strength 
(r = 0.5 - < 0.6). 
 
 
Discussion 
 
Depression can affect behaviour and 
contribute to adherence to therapy so that HIV 
infection damages immune function. A study by 
Moosa (2005) recruiting forty-one people aged 18 
years or over from an HIV outpatient clinic showed 
that about 56% of patients in this study had significant 
depressive symptoms (BDI > 10). However, this study 
did not find a significant correlation between BDI and 
CD4 scores (r = 0.274, p > 0.05) [13]. 
In this study, we also showed similar findings 
as described previously by Moosa et al., where BDI-II 
was an appropriate tool to determine depression in 
these patients. Nevertheless, our study was able to 
show a positive correlation between BDI-II scores and 
CD4 scores. This was in line with a longitudinal study 
conducted by Ironson et al., (2015) of 177 individuals 
with HIV/AIDS that underwent ARV treatment. The 
study showed that psychosocial and neurohormone 
influences the predictors of the progression of 
HIV/AIDS infection. Psychosocial factors determined 
by a high BDI score, high neurohormone factors such 
as cortisol and norepinephrine significantly affected 
the progression of HIV infection to AIDS by allowing a 
significant decrease in CD4 level and an increase in 
viral load [9]. 
In 2007, a study by Remor et al., at the 
Outpatient Clinic at the Madrid Teaching Hospital 
assessed psychological distress as measured by the 
PSS was associated with a decrease in CD4 level in 
59 men and 41 women living with HIV/AIDS within six 
months. The study showed that the perceived stress 
was significantly (p = 0,0001) associated with a 
decrease in CD4 level in people living with HIV, i.e. 
every increase in 1 point PSS score (score between 3 
and 43), is followed by a decrease in the score of 4.82 
of CD4 counts after observation for six months [15]. 
We did not follow the patients in our study. 
Nevertheless, we have shown that the PSS score had 
a moderate correlation with the CD4 level among our 
patients.  
In conclusion, we have shown a significant 
relationship between depression, stress and CD4 
level among people with HIV/AIDS in Medan, 
Indonesia. Psychological distress may affect the 
immunity in infected people, leading to the disease 
progressivity. Routine screening of psychosocial 
status in these population is important to determine 
their mental health status and allow early 
management and prevent disease progression. 
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